A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Conditions: Breast Carcinoma; Breast Ductal Carcinoma in Situ Interventions: Behavioral: Patient Navigatrion; Other: Questionnaire Sponsors: Roswell Park Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )
Conditions: Breast Carcinoma; Breast Carcinoma in Situ Interventions: Procedure: General Anaesthesia; Procedure: Local tumescent anaesthesia Sponsors: University Hospital Tuebingen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
Conditions: Bladder Cancer Interventions: Radiation: radiation therapy Sponsors: European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Conditions: Ductal Carcinoma in Situ Interventions: Biological: MUC1 Peptide Vaccine; Drug: Hiltonol ®; Drug: Aromatase Inhibitor Sponsors: Finn, Olivera, PhD; A Glimmer of Hope Foundation; Breast Cancer Research Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
Conditions: DCIS; Breast Carcinoma in Situ; Calcification Interventions: Diagnostic Test: Contrast Enhanced Mammography Sponsors: Clinical Hospital Center Rijeka Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Conditions: Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ Interventions: Procedure: Biospecimen Collection; Procedure: Mammography; Drug: Omega-3-Acid Ethyl Esters; Other: Questionnaire Administration; Procedure: Random Periareolar Fine-Needle Aspiration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Conditions: Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ; Estrogen Receptor-Positive Breast Carcinoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Mammography; Other: Questionnaire Administration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Conditions: Non Muscle Invasive Bladder Cancer; Non-Muscle Invasive Bladder Neoplasms; Non-Muscle Invasive Bladder Urothelial Carcinoma; Bladder Cancer; Bladder Disease; Bladder Neoplasm; Bladder Urothelial Carcinoma; Bladder Cancer Stage I, With Cancer in Situ; Bladder Cancer Recurrent; Bladder Urothelial Carcinoma in Situ; Bladder Urothelial Dysplasia Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Conditions: Facial Cutaneous Squamous Cell Carcinoma in Situ Interventions: Combination Product: Aminolevulinic Acid 20% Topical Solution with Blue Light Sponsors: The Center for Clinical and Cosmetic Research; Sun Pharmaceutical Industries Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management
Conditions: Pleomorphic Lobular Breast Carcinoma in Situ; Breast Florid Lobular Carcinoma in Situ Interventions: Procedure: Surgical wide local excision; Procedure: Cavity shaving; Procedure: Excision margin surgical clearance; Radiation: Adjuvant Radiotherapy; Biological: Adjuvant Hormone Therapy Sponsors: Istituto Oncologico Veneto IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Conditions: Breast Cancer; Breast Carcinoma in Situ; Breast Cancer Female Interventions: Other: Exercise Regimen Sponsors: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study
ConclusionsRecruitment to LORIS was challenging despite strategies aimed at both patients and site staff. Ensuring that recruiting staff support the study could improve recruitment in similar future trials.Trial registrationISRCTN27544579, prospectively registered on 22 May 2014 (Source: Trials)
Source: Trials - October 14, 2023 Category: Research Source Type: clinical trials
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Conditions: Ductal Carcinoma in Situ Interventions: Drug: Tamoxifen; Drug: Exemestane; Drug: Letrozole; Drug: Anastrazole; Drug: T+Ai; Drug: Elacestrant Sponsors: QuantumLeap Healthcare Collaborative Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologists
Conditions: Breast Cancer; Carcinoma in Situ Interventions: Other: Triage of clinical breast examination positive women using handheld ultrasound by non-radiologists. Sponsors: International Agency for Research on Cancer; Malabar Cancer Care Society Kannur, India; Bhabha Atomic Research Centre (BARC), India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates
Condition: Ductal Carcinoma in Situ Intervention: Procedure: Mastectomy with sentinel lymph node biopsy Sponsor: Gangnam Severance Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
